TF was highly expressed in both squamous cell carcinoma and adenocarcinoma of the cervix, whereas it was absent or minimally detected in normal cervical tissues, supporting its potential as a selective therapeutic target. This evidence concerns the gene TF and cervical adenocarcinoma.